SAN DIEGO, April 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma's registration statement issued in connection with Zenas...
Read More Details
Finally We wish PressBee provided you with enough information of ( ZBIO INVESTOR ALERT: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Palestinian activist Khalil denied release for son’s birth, wife says
- Education Ministry rehabilitates 70 schools since Assad regime’s fall
- Pope Francis’s will in full: Pontiff’s final wishes and place of burial